MiMedx Group Inc
NASDAQ:MDXG

Watchlist Manager
MiMedx Group Inc Logo
MiMedx Group Inc
NASDAQ:MDXG
Watchlist
Price: 9.23 USD 23.56% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
MiMedx Group Inc?
Write Note

MiMedx Group Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MiMedx Group Inc
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
MiMedx Group Inc
NASDAQ:MDXG
Total Equity
$181m
CAGR 3-Years
28%
CAGR 5-Years
36%
CAGR 10-Years
8%
Abbvie Inc
NYSE:ABBV
Total Equity
$6B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.4B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Equity
$7.5B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$15.6B
CAGR 3-Years
18%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$29.3B
CAGR 3-Years
19%
CAGR 5-Years
23%
CAGR 10-Years
28%

See Also

What is MiMedx Group Inc's Total Equity?
Total Equity
181m USD

Based on the financial report for Sep 30, 2024, MiMedx Group Inc's Total Equity amounts to 181m USD.

What is MiMedx Group Inc's Total Equity growth rate?
Total Equity CAGR 10Y
8%

Over the last year, the Total Equity growth was 93%. The average annual Total Equity growth rates for MiMedx Group Inc have been 28% over the past three years , 36% over the past five years , and 8% over the past ten years .

Back to Top